Antibiotic resistance is a growing issue that physicians and medical professionals worldwide cite as cause for concern. Researchers found that two protein families provide aid in processes that allow various bacteria to grow and survive.
Targeting these proteins is what could lead to the development of a new class of antibiotics that can fight a wider swath of pathogens, “including those that cause some of the world’s deadliest diseases, such as cholera,” according to a Feb. 16 press release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.